AIT与甲状腺癌
近期许多文献报告，甲状腺癌的甲状腺组织存在大量淋巴细胞浸润，特别是在乳头状甲状腺癌（PTC）。多数文献认为这是宿主的主动免疫反应，是肿瘤预后良好的独立因素。队列研究显示这个现象与PTC的腺外转移和淋巴结转移低发生率显著相关。
参考文献
[1] Hahsimoto H.Zur Kenntniss der lymphomato “sen Vera”nderung der Schilddru se (Struma lymphomatosa)[J].Arch Klin Chir,1912, 97:219-248.
[2] Joll C A.The pathology, diagnosis, and treatment of Hashimoto's disease (struma lymphomatosa)[J].Brit J Surg,1939, 27:351-389.
[3] Witebsky E, Rose N R.Studies on organ specificity: IV.Production of rabbit thyroid antibodies in the rabbits[J].J Immunol,1956, 76:408-416.
[4] Rose N R, Witebsky E.Studies on organ specificity:V.Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts[J].J Immunol,1956, 76:417-427.
[5] Roitt I M, Campbell P N, Doniach D.The nature of the thyroid autoantibodies present in patients with Hashimoto’s thyroiditis (lymphadenoid goitre)[J].Biochem J,1958, 69:248-256.
[6] Belyavin G, Trotter W R.Investigations of thyroid antigens reacting with Hashimoto sera.Evidence for an antigen other than thyroglobulin[J].Lancet,1959,1(7074):648-652.
[7] Hamada N, Grimm C, Mori H,et al.Identification of a thyroid II microsomal antigen by western blot and immunoprecipitation[J].J Clin Endocrinol Metab,1985,61:120-128.
[8] Leslie J DeGroot，J Larry Jameson：Endocrinology[M].7th Edition W.B.Saunders Company,2016.
[9] Vanderpump M P J.The epidemiology of thyroid disease[J].British Medical Bulletin, 2011,99:39-51.
[10] Biondi B, Cooper D C.The clinical significance of subclinical thyroid dysfunction[J].Endocr Rev,2008,29(1):76-131.
[11] M.P.Vanderpump, W.M.Tunbridge, J.M.French, et al.The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey[J].Clin Endocrinol (Oxf), 1995,43(1): 55-68.
[12] Hollowell J G, Staehling N W, Flanders W D, et al.Serum TSH, T(4), and thyroid antibodies in the United States population (1988—1994): National Health and Nutrition Examination Survey (NHANES Ⅲ) [J].J Clin Endocrinol Metab, 2002,87:489-499.
[13] Teng W, Shan Z, Teng X, et al.Effect of iodine intake on thyroid diseases in China[J].N Engl J Med, 2006, 354:2783-2793.
[14] Shan Z Y, Teng W P.Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 15 years in China: A cross-sectional study in 10 cities[J].Thyroid, 2016,26:1125-1130.
[15] Vanderpump M P J, Tunbridge W M G, French J M,et al.The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey[J].Clin Endocrinol (Oxf), 1995,43:55-69.
[16] Li YS, Teng D，Shan Z Y,et al.Antithyroperoxidase and Antithyroglobulin Antibodies in a Five-Year Follow-Up Survey of Populations with Different Iodine Intakes[J].J Clin Endocrinol Metab, 2008, 93: 1751-1757.
[17] Strieder T G, Tijssen J G, Wenzel B E,et al.Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA)score[J].Arch Intern Med, 2008,168:1657-1663.
[18] Kronenberg H M, Melmed S, Polonsky K S,et al.Willimas Textbook of Endocrinology[M].11th Edition,Elesevier,2008.
[19] Li Y, Bai Y, Liu Z,et al.Immunohistochemistry of IgG4 can help subclassify Hashimoto’s autoimmune thyroiditis[J].Pathol Int, 2009,59(9):636-641.
[20] Meng Z W，Zhang G Z，Sun H，et al.Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake,thyroid scintigraphy and serum parameters[J].Experimental Therapeutic Medicine, 2015,9:2165-2172.
[21] Okayasu I, Hara Y, Nakamura K, et al.Racial and agerelated difference in incidence and severity of focal autoimmune thyroiditis[J].Am J Clin Pathol, 1994,101:608-672.
[22] 李晨阳，关海霞，滕卫平，等.产后甲状腺炎的前瞻性临床流行病学调查[J].中华内分泌代谢杂志，2005，21（2）：99-102.(https://www.daowen.com)
[23] Guan H X,Li C Y,Teng W P,et al.High iodine intake is a risk factor of postpartum thyroiditis: results of a survey from Shenyang China[J].J Endocrinol Invest,2005,28(10):876-881.
[24] Li Y, Zhou G, Ozaki T, et al.Distinct histopathological features of Hashimoto's thyroiditis with respect to IgG4-related disease[J].Mod Pathol, 2012,25:1086-1097.
[25] Watanabe T,Maruyama M, Ito T, et al.Clinical features of a new disease concept, IgG4-related thyroiditis[J].Scand J Rheumatol, 2013,42:325-330.
[26] Wasniewska M, Corrias A, Salerno M, et al.Thyroid function patterns at Hashimoto's thyroiditis presentation in childhood and adolescence are mainly conditioned by patients’age[J].Horm Res Paediatr, 2012,78:232-336.
[27] Radetti G，Gottardi E，Bona G，et al.The natural history of euthyroid Hashimoto thyroiditis[J].J Pediatr,2006,149:827-832.
[28] Tamai H, Kasagi K, Takaichi Y, et al.Development of spontaneous hypothyroidism in patients with Graves’disease treated with antithyroidal drugs: clinical,immunological, and histological findings in 26 patients[J].J Clin Endocrinol Metab,1989,69:49-53.
[29] Takasu N, Matsushita M.Changes of TSH-stimulation blocking antibody (TSBAb) and thyroid stimulating antibody (TSAb) over 10 years in 34 TSBAb-positive patients with hypothyroidism and in 98 TSAbpositive Graves’' Patients With Hyperthyroidism:Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients[J].J Thyroid Res,2012,2012:182176.
[30] Laurent C, Capron J, Quillerou B,et al.Steroid-responsive encephalopathy associated with autoimmune thyroiditis(SREAT): Characteristics, treatment and outcome in 251 cases from the literature[J].Autoimmunity Review,2016,15:1129-1133.
[31] Gini B, Laura L, Riccardo C, et al.Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach[J].J Neuroimmunol,2008,196:153-158.
[32] Blanchin S, Coffin C, Viader F, et al.Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes[J].J Neuroimmunol,2007,192:13-20.
[33] Larson S D, Jackson L N, Riall T S, et al.Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway[J].J Am Coll Surg, 2007,204:764-773.
[34] Paiva1 C R, Gronhoj C, Rasmussen U F and Buchwald C.Association between hashimoto’s Thyroiditis and Thyroid cancer in 64,628 Patients[J].Front Oncol, 2017,7:53.
[35] La’ulu Sonia L, Roberts William L,Slev Patricia R.Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays[J].Clin Chim Acta, 2007,376: 88-95.
[36] Demers L，Spencer C A, Laurence M.Demers.Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease[J].Thyroid,2003,13(1):3-126.
[37] Li Y，Teng D，Shan Z Y,et al.Antithyroperoxidase and Antithyroglobulin Antibodies in a Five-Year Follow-Up Survey of Populations with Different Iodine Intakes[J] .J Clin Endocrinol Metab,2008, 93: 1751-1757.
[38] Carle A, Laurberg P, Knudsen N, et al.Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism[J].Autoimmunity,2006,39:497-503.
[39] Rose N R.Autoimmune escalation: through the crystal ball[J].Clin Exp Immunol, 2007, 147:9.
[40] Chen C R, Hamidi S, Braley-Mullen H, et al.Antibodies to thyroid peroxidase arise spontaneously with age in NOD.H-2h4 mice and appear after thyroglobulin antibodies[J].Endocrinology, 2010,151:4583-4593.
[41] Tamai H, Kasagi K, Takaichi Y,et al.Development of spontaneous hypothyroidism in patients with Graves’disease treated with antithyroidal drugs: clinical,immunological, and histological findings in 26 patients[J].J Clin Endocrinol Metab,1989, 69:49-53.
[42] Evans M, Sanders J, Tagami T, et al.Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample[J].Clin Endocrinol (Oxf),2010,73:404-412.
[43] McLachlan SM, Rapoport B.Thyrotropin-Blocking Autoantibodies and Thyroid- Stimulating Autoantibodies:Potential Mechanisms Involved in the Pendulum Swinging from Hypothyroidism to Hyperthyroidism or Vice Versa[J].Thyroid, 2013,23:14-24.
[44] Willms A.Correlation Between Sonography and Antibody Activity in Patients With Hashimoto Thyroiditis[J].J Ultrasound Med, 2013, 32:1979-1986.
[45] Harvey A M, Truong L D, Mody D R.Diagnostic pitfalls of Hashimoto's/lymphocytic thyroiditis on fine-needle aspirations and strategies to avoid overdiagnosis[J].Acta Cytol, 2012,56:352-360.
[46] Rossi E D, Martini M, Straccia P, et al.The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesionsat histology.An institutional experience[J].Eur J Endocrinol, 2013, 169(5):649-655.